Nagalingeswaran Kumarasamy, CROI 2022: Phase III Trial of Molnupiravir in Adults with COVID-19 in India
Molnupiravir was developed in response to an urgent unmet need for an orally administered antiviral drug to prevent disease progression in patients with COVID-19. Dr Nagalingeswaran Kumarasamy (Voluntary Health Services Hospital, Chennai, Southern India) discusses the phase III study assessing the efficacy and safety of molnupiravir in Indian patients with mild SARS-CoV2 infection.
The abstract entitled: ‘Phase III Trial of Molnupiravir in Adults with Mild Sars-Cov-2 Infection in India’ (Abstract #101) was presented at Conference on Retroviruses and Opportunistic Infections (CROI) 2022 (Virtual), 12-16 February 2022.
- Could you give us a brief overview of the Phase III Molnupiravir clinical trial in India, and the key study findings? (0:34)
- What questions remain unanswered and what will be the next steps for Molnupiravir as a treatment for COVID-19? (6:14)
Disclosures: Nagalingeswaran Kumarasamy has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of CROI 2022
Share this Video
Related Videos In COVID-19
Viki Male: COVID-19 and family planning – Impacts of vaccination and infection
Dr Victoria (Viki) Male (Imperial College London, London, UK) explores how COVID-19 infection can impact fertility and reproductive health, and discuss potential precautions individuals living in the UK can take. Dr Male also addresses what couples trying to conceive should know about COVID-19 vaccination, and what is currently known about the impact of vaccination on […]
Viki Male: Navigating concerns about menstrual cycle changes after COVID-19 vaccination
The effects of COVID-19 vaccination on women’s menstrual cycles have been a recent topic of interest and concern. Dr Victoria (Viki) Male (Imperial College London, London, UK) addresses that there have been some reported changes in women’s menstrual cycles after receiving a COVID-19 vaccine. The mechanisms behind these changes are not yet fully understood, but […]
Viki Male: COVID-19 infection and vaccination during pregnancy and breastfeeding, understanding the risks and benefits
Dr Victoria (Viki) Male (Imperial College London, London, UK) delves into the impact of COVID-19 on pregnancy, and the current recommendations for COVID-19 vaccination for pregnant and breastfeeding women in this touchINFECTIOUS DISEASES interview. Dr Male also shares insight into the known efficacy and safety profile of COVID-19 vaccines in pregnant and breastfeeding women, as […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!